TY  - JOUR
EP  - 503
JF  - INFLAMMATION RESEARCH
ID  - publicatio32490
UR  - https://doi.org/10.1007/BF01837917
N2  - Histamine has inotropic, chronotropic, arrhythmogenic, and vasoactive effects, and is released from the heart in ischaemia-reperfusion injury. The effect of ventricular fibrillation (VF) and defibrillation (DEF) on histamine release was investigated in 9 anaesthetized patients undergoing transvenous implantation of ICD. Concomitant arterial and coronary sinus (CS) blood samples were drawn before induction of VF (duration 20 seconds), immediately after, and 2 and 5 min after DEF (18-24 Joules). Basal 2.5 +/- 6 nmol/l, and did not histamine level in CS was 1.1 +/- 0.2 nmol/l before VF (p < 0.008 compared to arterial), and increased to 2.5 +/- 0.6 nmol/l immediately after (p < 0.045 compared to basal), to 3 +/- 1.1 nmol/l 2 mill after (p < 0.45), and to 2.4 +/- 0.8 nmol/l 5 mill after VF. In the basal state there was an uptake of histamine across the coronary circulation. After VF/DEF the level of histamine increased in corollary venous blood, suggesting cardiac release of histamine.
A1  -  Valen G.
A1  -  Runsiö M.
A1  -  Öwall A.
A1  -  Kaszaki József
A1  -  Nagy Sándor
A1  -  Rosenqvist M.
A1  -  Bergfieldt L.
A1  -  Vaage J.
SP  - 499
IS  - 11
TI  - CARDIAC RELEASE OF HISTAMINE AFTER VENTRICULAR-FIBRILLATION AND DEFIBRILLATION DURING INSERTION OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICD)
SN  - 1023-3830
Y1  - 1995///
VL  - 44
AV  - restricted
ER  -